Cargando…

Scleroderma-related interstitial lung disease

Scleroderma-related interstitial lung disease (SSc-ILD) is a pulmonary fibrosing disorder characterized by systemic inflammation and progressive scarring of the lungs that leads to respiratory failure. Although certain immunosuppressive therapies may slow disease progression, current treatment strat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suliman, Sally, Al Harash, Abdalhamid, Roberts, William Neil, Perez, Rafael L., Roman, Jesse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524221/ https://www.ncbi.nlm.nih.gov/pubmed/28761806 http://dx.doi.org/10.1016/j.rmcr.2017.07.007

Ejemplares similares

Scleroderma and interstitial lung disease - A case report
por: Gul, Fahad, et al.
Publicado: (2022)

Emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
por: Stock, Carmel J. W., et al.
Publicado: (2020)

Challenges in Treating Statin-Associated Necrotizing Myopathy
por: Webster, Patrick, et al.
Publicado: (2021)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Type 2 cytokines and scleroderma interstitial lung disease
por: Pellicano, Chiara, et al.
Publicado: (2023)

IgA Vasculitis Nephritis: A Case Series and Comparison of Treatment Guidelines
por: Al Harash, Abdalhamid, et al.
Publicado: (2020)

Variation of usual interstitial pneumonia using HRCT in Scleroderma Patients
por: Wulani, Vally, et al.
Publicado: (2021)

Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
por: Baqir, Misbah, et al.
Publicado: (2017)

Scleroderma-related choroiditis
por: Majumder, Parthopratim Dutta, et al.
Publicado: (2018)

Atypical emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia: a case report
por: Jazia, Rahma Ben, et al.
Publicado: (2022)

Safety and Tolerability of Thrombin Inhibition in Scleroderma‐Associated Interstitial Lung Disease
por: Silver, R. M., et al.
Publicado: (2019)

A case of sine scleroderma with parenchymal lung disease
por: Karimifar, Mansoor, et al.
Publicado: (2014)

Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease
por: Woo, Samuel, et al.
Publicado: (2023)

Scleroderma renal crisis during intravenous cyclophosphamide pulse therapy for complicated interstitial lung disease was successfully treated with angiotensin converting enzyme inhibitor and plasma exchange
por: Nagamura, Norihiro, et al.
Publicado: (2016)

Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma
por: Ferreira, João Pedro, et al.
Publicado: (2012)

Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma
por: Yoshioka, Fumie, et al.
Publicado: (2023)

Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States
por: Bernstein, Elana J., et al.
Publicado: (2022)

Long Term Effects of Cyclophosphamide Treatment on Lung Function and Survival in Scleroderma Patients with Interstitial Lung Disease
por: Mittoo, S, et al.
Publicado: (2011)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial
por: Tashkin, Donald P, et al.
Publicado: (2016)

Endothelial lesion and complement activation in patients with Scleroderma Renal Crisis
por: Pérez, Ney Arencibia, et al.
Publicado: (2019)

Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis–associated interstitial lung disease trials
por: Khanna, Dinesh, et al.
Publicado: (2015)

Shrinking lung syndrome in systemic lupus erythematosus-scleroderma overlap
por: Guleria, Vivek S., et al.
Publicado: (2014)

Phaeochromocytoma Mimicking Scleroderma
por: Khoo, Joan Joo-Ching, et al.
Publicado: (2011)

Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
por: Khanna, Surabhi Agarwal, et al.
Publicado: (2022)

A Case of Intravascular Diffuse Large B-Cell Lymphoma Initially Suspected as Interstitial Pneumonia Associated With Systemic Scleroderma
por: Oguri, Tomoyo, et al.
Publicado: (2021)

Scleroderma of geriatric age and scleroderma-like paraneoplastic syndrome – description of two cases
por: Marek, Magdalena, et al.
Publicado: (2016)

Carcinoid Syndrome-Induced Scleroderma-Like Disease
por: Koch, Karen, et al.
Publicado: (2019)

Scleroderma as an Uncommon Cause of Pericardial Effusion
por: Yee, Brianna L., et al.
Publicado: (2022)

Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension
por: Sugino, Keishi, et al.
Publicado: (2018)

Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease
por: Vrancken, Anniek, et al.
Publicado: (2015)

Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib
por: Wang, Dandan, et al.
Publicado: (2023)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022)

Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease
por: Dsouza, Kevin G., et al.
Publicado: (2023)

Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
por: Khanna, Surabhi Agarwal, et al.
Publicado: (2022)

A Case of IgG4-Related Lung Disease Presenting as Interstitial Lung Disease
por: Ahn, Jee Hwan, et al.
Publicado: (2014)

A case of orf disease in a patient with scleroderma
por: Maor, Danit, et al.
Publicado: (2017)

An unusual case of interstitial lung disease: Revisiting peribronchiolar metaplasia interstitial lung disease (PBM‐ILD)
por: Jung, Flora, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mhujnhbg5lins4coohqvql76do